IBIOiBio, Inc.

NYSE ibioinc.com


$ 1.68 $ -0.10 (-5.68 %)    

Monday, 29-Apr-2024 15:59:32 EDT
QQQ $ 433.04 $ 1.75 (0.41 %)
DIA $ 383.81 $ 1.49 (0.39 %)
SPY $ 510.06 $ 1.80 (0.35 %)
TLT $ 88.99 $ 0.74 (0.84 %)
GLD $ 216.18 $ -0.44 (-0.2 %)
$ 1.66
$ 1.75
$ 0.00 x 0
$ 0.00 x 0
$ 1.66 - $ 1.77
$ 1.02 - $ 22.80
292,887
na
3.08M
$ -3.65
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-09-2024 12-31-2023 10-Q
2 11-14-2023 09-30-2023 10-Q
3 09-27-2023 06-30-2023 10-K
4 05-15-2023 03-31-2023 10-Q
5 02-14-2023 12-31-2022 10-Q
6 11-14-2022 09-30-2022 10-Q
7 10-11-2022 06-30-2022 10-K
8 05-12-2022 03-31-2022 10-Q
9 02-14-2022 12-31-2021 10-Q
10 11-15-2021 09-30-2021 10-Q
11 09-28-2021 06-30-2021 10-K
12 05-17-2021 03-31-2021 10-Q
13 02-16-2021 12-31-2020 10-Q
14 11-16-2020 09-30-2020 10-Q
15 10-13-2020 06-30-2020 10-K
16 05-15-2020 03-31-2020 10-Q
17 02-14-2020 12-31-2019 10-Q
18 11-14-2019 09-30-2019 10-Q
19 08-26-2019 06-30-2019 10-K
20 05-10-2019 03-31-2019 10-Q
21 02-13-2019 12-31-2018 10-Q
22 11-13-2018 09-30-2018 10-Q
23 09-18-2018 06-30-2018 10-K
24 05-11-2018 03-31-2018 10-Q
25 02-14-2018 12-31-2017 10-Q
26 11-09-2017 09-30-2017 10-Q
27 09-15-2017 06-30-2017 10-K
28 05-15-2017 03-31-2017 10-Q
29 02-21-2017 12-31-2016 10-Q
30 11-18-2016 09-30-2016 10-Q
31 10-13-2016 06-30-2016 10-K
32 05-23-2016 03-31-2016 10-Q
33 02-22-2016 12-31-2015 10-Q
34 11-13-2015 09-30-2015 10-Q
35 10-13-2015 06-30-2015 10-K
36 05-15-2015 03-31-2015 10-Q
37 02-23-2015 12-31-2014 10-Q
38 11-14-2014 09-30-2014 10-Q
39 09-29-2014 06-30-2014 10-K
40 05-15-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ibio-files-prospectus-relates-to-resale-from-time-to-time-of-up-to-106m-shares-of-common-stock-by-selling-stockholders

-SEC Filing

 micro-cap-stock-ibio-doubles-on-wednesday---heres-why

iBio surged after collaborating with AstralBio Inc. to develop antibodies for obesity & cardiometabolic conditions. Shares ...

Core News & Articles
Market-Moving News for March 27th
03/27/2024 12:31:22

IBIO: 119% | IBio shares are trading higher after the company collaborated with AstralBio for AI drug-powered antibodies for ob...

 ibio-and-astralbio-announce-transformative-ai-drug-discovery-collaboration-to-rapidly-develop-novel-antibodies-for-obesity-and-cardiometabolic-diseases

iBio, Inc. (NYSEA:IBIO) ("iBio" or the "Company") announces today that it has entered into a collaboration agre...

 reported-earlier-ibio-raises-15m-in-equity-financing-shares-set-at-285-each

iBio, Inc.  an AI-driven innovator of precision antibody immunotherapies, announces today that it has entered into a securities...

 top-4-health-care-stocks-that-may-rocket-higher-in-q1

The most oversold stocks in the health care presents an opportunity to buy into undervalued companies.

 crude-oil-moves-lower-autozone-profit-tops-views

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher on Tuesday. The Dow traded down 0...

 why-daktronics-shares-are-trading-lower-by-over-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results.

 dow-falls-100-points-ism-services-pmi-increases-in-november

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 100 points on Tuesday. The Dow traded...

 us-stocks-down-jm-smucker-posts-upbeat-earnings

U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 50 points on Tuesday. Following the market openi...

 why-gitlab-shares-are-trading-higher-by-over-16-here-are-20-stocks-moving-premarket

Shares of GitLab Inc. (NASDAQ: GTLB) rose sharply in pre-market trading after the company posted better-than-expected results ...

 ibio-inc-announces-pricing-of-45m-public-offering

iBio, Inc. (NYSEA:IBIO) ("iBio" or the "Company"), today announced the pricing of its reasonable best efforts p...

 why-ibio-stock-is-plunging-sharply

iBio, Inc. (NASDAQ: IBIO) recently approved a 20-to-1 reverse stock split of its common stock, which will take effect on Novemb...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION